PDB Short entry for 4P4C HEADER TRANSFERASE/TRANSFERASE INHIBITOR 12-MAR-14 4P4C TITLE HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH QUINOXALINE DERIVATIVES COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPH RECEPTOR A3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EPHA3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: P28-LIC-THROMBIN KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.DONG,A.CAFLISCH REVDAT 4 27-SEP-23 4P4C 1 REMARK REVDAT 3 22-NOV-17 4P4C 1 SOURCE JRNL REMARK REVDAT 2 01-OCT-14 4P4C 1 JRNL REVDAT 1 13-AUG-14 4P4C 0 JRNL AUTH A.UNZUE,J.DONG,K.LAFLEUR,H.ZHAO,E.FRUGIER,A.CAFLISCH, JRNL AUTH 2 C.NEVADO JRNL TITL PYRROLO[3,2-B]QUINOXALINE DERIVATIVES AS TYPES I1/2 AND II JRNL TITL 2 EPH TYROSINE KINASE INHIBITORS: STRUCTURE-BASED DESIGN, JRNL TITL 3 SYNTHESIS, AND IN VIVO VALIDATION. JRNL REF J.MED.CHEM. V. 57 6834 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 25076195 JRNL DOI 10.1021/JM5009242 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.64 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 39350 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1964 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.6503 - 3.8517 0.95 2677 159 0.1637 0.1705 REMARK 3 2 3.8517 - 3.0579 0.98 2715 148 0.1606 0.1914 REMARK 3 3 3.0579 - 2.6715 0.99 2715 133 0.1785 0.1920 REMARK 3 4 2.6715 - 2.4273 0.98 2707 135 0.1845 0.2337 REMARK 3 5 2.4273 - 2.2534 0.99 2657 151 0.1785 0.1882 REMARK 3 6 2.2534 - 2.1206 0.97 2622 146 0.1769 0.2160 REMARK 3 7 2.1206 - 2.0144 0.95 2608 121 0.1792 0.2007 REMARK 3 8 2.0144 - 1.9267 0.99 2677 160 0.1858 0.2178 REMARK 3 9 1.9267 - 1.8525 0.96 2599 130 0.2059 0.2430 REMARK 3 10 1.8525 - 1.7886 1.00 2711 135 0.1958 0.2504 REMARK 3 11 1.7886 - 1.7327 1.00 2682 139 0.1953 0.2381 REMARK 3 12 1.7327 - 1.6832 1.00 2724 145 0.2078 0.2326 REMARK 3 13 1.6832 - 1.6388 1.00 2698 126 0.2011 0.2387 REMARK 3 14 1.6388 - 1.5990 0.95 2594 136 0.2085 0.2135 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.630 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.42 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2179 REMARK 3 ANGLE : 1.343 2943 REMARK 3 CHIRALITY : 0.050 324 REMARK 3 PLANARITY : 0.005 369 REMARK 3 DIHEDRAL : 14.051 819 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4P4C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1000200674. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99989 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XSCALE REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16, XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39425 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.599 REMARK 200 RESOLUTION RANGE LOW (A) : 38.164 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.31700 REMARK 200 R SYM FOR SHELL (I) : 0.31700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2GSF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M SODIUM CACODYLATE PH 6.5, 0.15M REMARK 280 AMMONIUM SULFATE, 22.5% PEG 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 19.08200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 587 REMARK 465 GLY A 588 REMARK 465 SER A 589 REMARK 465 SER A 590 REMARK 465 HIS A 591 REMARK 465 HIS A 592 REMARK 465 HIS A 593 REMARK 465 HIS A 594 REMARK 465 HIS A 595 REMARK 465 HIS A 596 REMARK 465 SER A 597 REMARK 465 SER A 598 REMARK 465 GLY A 599 REMARK 465 LEU A 600 REMARK 465 VAL A 601 REMARK 465 PRO A 602 REMARK 465 ARG A 603 REMARK 465 GLY A 604 REMARK 465 SER A 605 REMARK 465 THR A 606 REMARK 465 GLN A 607 REMARK 465 THR A 608 REMARK 465 VAL A 609 REMARK 465 HIS A 610 REMARK 465 GLU A 611 REMARK 465 PHE A 612 REMARK 465 GLY A 766 REMARK 465 LEU A 767 REMARK 465 SER A 768 REMARK 465 ARG A 769 REMARK 465 VAL A 770 REMARK 465 LEU A 771 REMARK 465 GLU A 772 REMARK 465 ASP A 773 REMARK 465 ASP A 774 REMARK 465 PRO A 775 REMARK 465 GLU A 776 REMARK 465 ALA A 777 REMARK 465 ALA A 778 REMARK 465 TYR A 779 REMARK 465 THR A 780 REMARK 465 THR A 781 REMARK 465 ARG A 782 REMARK 465 GLY A 783 REMARK 465 GLY A 784 REMARK 465 LYS A 785 REMARK 465 ILE A 786 REMARK 465 SER A 893 REMARK 465 ALA A 894 REMARK 465 ALA A 895 REMARK 465 ALA A 896 REMARK 465 ARG A 897 REMARK 465 GLN A 905 REMARK 465 SER A 906 REMARK 465 ASN A 907 REMARK 465 VAL A 908 REMARK 465 ASP A 909 REMARK 465 ILE A 910 REMARK 465 THR A 911 REMARK 465 THR A 912 REMARK 465 PHE A 913 REMARK 465 ARG A 914 REMARK 465 THR A 915 REMARK 465 THR A 916 REMARK 465 GLY A 917 REMARK 465 ASP A 918 REMARK 465 TRP A 919 REMARK 465 LEU A 920 REMARK 465 ASN A 921 REMARK 465 GLY A 922 REMARK 465 VAL A 923 REMARK 465 TRP A 924 REMARK 465 THR A 925 REMARK 465 ALA A 926 REMARK 465 HIS A 927 REMARK 465 CYS A 928 REMARK 465 LYS A 929 REMARK 465 GLU A 930 REMARK 465 ILE A 931 REMARK 465 PHE A 932 REMARK 465 THR A 933 REMARK 465 GLY A 934 REMARK 465 VAL A 935 REMARK 465 GLU A 936 REMARK 465 TYR A 937 REMARK 465 SER A 938 REMARK 465 SER A 939 REMARK 465 CYS A 940 REMARK 465 ASP A 941 REMARK 465 THR A 942 REMARK 465 ILE A 943 REMARK 465 ALA A 944 REMARK 465 LYS A 945 REMARK 465 ILE A 946 REMARK 465 SER A 947 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 645 -5.91 83.67 REMARK 500 ARG A 745 -9.62 78.06 REMARK 500 SER A 763 -167.77 -128.35 REMARK 500 ASP A 764 68.23 63.56 REMARK 500 TYR A 798 30.56 -149.03 REMARK 500 TRP A 826 -129.03 53.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1311 DISTANCE = 6.73 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 25Q A 1001 DBREF 4P4C A 606 947 UNP Q6P4R6 Q6P4R6_HUMAN 606 947 SEQADV 4P4C MET A 587 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C GLY A 588 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C SER A 589 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C SER A 590 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C HIS A 591 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C HIS A 592 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C HIS A 593 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C HIS A 594 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C HIS A 595 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C HIS A 596 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C SER A 597 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C SER A 598 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C GLY A 599 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C LEU A 600 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C VAL A 601 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C PRO A 602 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C ARG A 603 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C GLY A 604 UNP Q6P4R6 EXPRESSION TAG SEQADV 4P4C SER A 605 UNP Q6P4R6 EXPRESSION TAG SEQRES 1 A 361 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 361 LEU VAL PRO ARG GLY SER THR GLN THR VAL HIS GLU PHE SEQRES 3 A 361 ALA LYS GLU LEU ASP ALA THR ASN ILE SER ILE ASP LYS SEQRES 4 A 361 VAL VAL GLY ALA GLY GLU PHE GLY GLU VAL CYS SER GLY SEQRES 5 A 361 ARG LEU LYS LEU PRO SER LYS LYS GLU ILE SER VAL ALA SEQRES 6 A 361 ILE LYS THR LEU LYS VAL GLY TYR THR GLU LYS GLN ARG SEQRES 7 A 361 ARG ASP PHE LEU GLY GLU ALA SER ILE MET GLY GLN PHE SEQRES 8 A 361 ASP HIS PRO ASN ILE ILE ARG LEU GLU GLY VAL VAL THR SEQRES 9 A 361 LYS SER LYS PRO VAL MET ILE VAL THR GLU TYR MET GLU SEQRES 10 A 361 ASN GLY SER LEU ASP SER PHE LEU ARG LYS HIS ASP ALA SEQRES 11 A 361 GLN PHE THR VAL ILE GLN LEU VAL GLY MET LEU ARG GLY SEQRES 12 A 361 ILE ALA SER GLY MET LYS TYR LEU SER ASP MET GLY TYR SEQRES 13 A 361 VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU ILE ASN SEQRES 14 A 361 SER ASN LEU VAL CYS LYS VAL SER ASP PHE GLY LEU SER SEQRES 15 A 361 ARG VAL LEU GLU ASP ASP PRO GLU ALA ALA TYR THR THR SEQRES 16 A 361 ARG GLY GLY LYS ILE PRO ILE ARG TRP THR SER PRO GLU SEQRES 17 A 361 ALA ILE ALA TYR ARG LYS PHE THR SER ALA SER ASP VAL SEQRES 18 A 361 TRP SER TYR GLY ILE VAL LEU TRP GLU VAL MET SER TYR SEQRES 19 A 361 GLY GLU ARG PRO TYR TRP GLU MET SER ASN GLN ASP VAL SEQRES 20 A 361 ILE LYS ALA VAL ASP GLU GLY TYR ARG LEU PRO PRO PRO SEQRES 21 A 361 MET ASP CYS PRO ALA ALA LEU TYR GLN LEU MET LEU ASP SEQRES 22 A 361 CYS TRP GLN LYS ASP ARG ASN ASN ARG PRO LYS PHE GLU SEQRES 23 A 361 GLN ILE VAL SER ILE LEU ASP LYS LEU ILE ARG ASN PRO SEQRES 24 A 361 GLY SER LEU LYS ILE ILE THR SER ALA ALA ALA ARG PRO SEQRES 25 A 361 SER ASN LEU LEU LEU ASP GLN SER ASN VAL ASP ILE THR SEQRES 26 A 361 THR PHE ARG THR THR GLY ASP TRP LEU ASN GLY VAL TRP SEQRES 27 A 361 THR ALA HIS CYS LYS GLU ILE PHE THR GLY VAL GLU TYR SEQRES 28 A 361 SER SER CYS ASP THR ILE ALA LYS ILE SER HET 25Q A1001 25 HETNAM 25Q 2-AMINO-1-(3-METHOXYPHENYL)-1H-PYRROLO[2,3- HETNAM 2 25Q B]QUINOXALINE-3-CARBOXAMIDE FORMUL 2 25Q C18 H15 N5 O2 FORMUL 3 HOH *274(H2 O) HELIX 1 AA1 ASP A 617 THR A 619 5 3 HELIX 2 AA2 THR A 660 GLY A 675 1 16 HELIX 3 AA3 SER A 706 LYS A 713 1 8 HELIX 4 AA4 THR A 719 MET A 740 1 22 HELIX 5 AA5 ALA A 748 ARG A 750 5 3 HELIX 6 AA6 PRO A 787 THR A 791 5 5 HELIX 7 AA7 SER A 792 ARG A 799 1 8 HELIX 8 AA8 THR A 802 SER A 819 1 18 HELIX 9 AA9 SER A 829 GLU A 839 1 11 HELIX 10 AB1 PRO A 850 TRP A 861 1 12 HELIX 11 AB2 ASP A 864 ARG A 868 5 5 HELIX 12 AB3 LYS A 870 ASN A 884 1 15 HELIX 13 AB4 PRO A 885 ILE A 890 5 6 SHEET 1 AA1 5 ILE A 621 ALA A 629 0 SHEET 2 AA1 5 GLU A 634 LYS A 641 -1 O SER A 637 N LYS A 625 SHEET 3 AA1 5 GLU A 647 THR A 654 -1 O ILE A 652 N CYS A 636 SHEET 4 AA1 5 MET A 696 GLU A 700 -1 O ILE A 697 N LYS A 653 SHEET 5 AA1 5 LEU A 685 VAL A 689 -1 N GLY A 687 O VAL A 698 SHEET 1 AA2 2 ILE A 752 ILE A 754 0 SHEET 2 AA2 2 CYS A 760 VAL A 762 -1 O LYS A 761 N LEU A 753 SHEET 1 AA3 2 TYR A 841 ARG A 842 0 SHEET 2 AA3 2 LEU A 902 LEU A 903 -1 O LEU A 902 N ARG A 842 CISPEP 1 LYS A 693 PRO A 694 0 1.92 SITE 1 AC1 10 ALA A 651 LYS A 653 GLU A 670 ILE A 697 SITE 2 AC1 10 THR A 699 GLU A 700 TYR A 701 MET A 702 SITE 3 AC1 10 LEU A 753 SER A 763 CRYST1 53.914 38.164 75.527 90.00 101.59 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018548 0.000000 0.003805 0.00000 SCALE2 0.000000 0.026203 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013516 0.00000